By using a highly sensitive and specific combinatorial tetramer staining and enrichment strategy, we showed that the ex vivo frequencies of myelin-specific CD8+ T cells in the peripheral blood did not differ between MS patients and MHC I allele-matched control subjects. Here, CD8A is linked to myeloid sarcoma.